A Study of LP-128 Capsules in Healthy Subjects

Exclusion Criteria

• •Abnormal vital signs, physical examination or laboratory tests with clinical significance
• •Abnormal ECG, chest X-ray, abdominal ultrasound or echocardiography with clinical significance
• •Positive screening for viral hepatitis, HIV and syphilis
• •Subjects who have taken any drugs or health care products within 14 or 28 days before administration the study drug; or subjects who have consumed tea or alcohol-containing food product within 24hrs before administration the study drug
• •Subjects who have a history of dysphagia or condition may affect drug absorption, distribution, metabolism and excretion
• •Female subjects are breastfeeding or pregnant
• •Subjects who have a history of drug/alcohol/tobacco abuse
• •Subjects who have had a blood donation or massive blood loss within three months before screening; or had major surgery within six months before screening
• •Subjects who have participated in other clinical trial within three months before screening
• •Subjects have special dietary requirements or cannot tolerate a standard meal
• •Subjects who are not suitable for this trial based on the assessment of investigator